Collaborative Working Project Summary Report on Atrial Fibrillation

This document is a summary report detailing the collaborative working project between the Birmingham and Solihull Integrated Care Board (ICB) and Bristol-Myers Squibb (BMS) on behalf of the BMS-Pfizer Alliance. The primary objective of the project was to reduce the number of avoidable strokes related to atrial fibrillation (AF) across the ICB. The report outlines the project's duration from July 2021 to December 2022, during which there was a noted improvement in AF management and treatment by 3.55% across the ICB footprint. The project aimed to standardize access to services through pathway redesign and enhance support for healthcare professionals and patients. Key learnings and insights from the project are documented, which may inform future collaborative initiatives. The report also discusses the unmet patient needs and the potential for replicating the project in other localities, emphasizing the importance of early detection and effective management of AF to improve patient outcomes.